Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT02738385 Completed - Metabolic Diseases Clinical Trials

Intensity Training and Cardiovascular Health in Colombian Adults

HIIT-Heart
Start date: June 2015
Phase: N/A
Study type: Interventional

Several studies have shown relationship between exercise intensity and improvement cardiometabolic health. It has been suggested that high intensity interval training and also moderate training generate positive effects on metabolic risk factors. For these reasons, it is necessary to clarify which type of training, is more effective to improve cardiometabolic health in latinamerican population.

NCT ID: NCT02731820 Completed - Osteopenia Clinical Trials

Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia

ACAROS
Start date: September 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether the use of alkali compounds, i.e. potassium citrate (K3C6H5O7, hereinafter KCitr) is effective in preventing the progression of osteopenia. A randomized clinical trial (RCT, placebo-controlled, double-blind) has been planned to evaluate the effect of the daily administration of KCitr (3 g/die, K 30 mEq). The efficacy will be evaluated by comparing the circulating levels of bone turnover markers at the baseline and after the treatment (3, 6 months).

NCT ID: NCT02718885 Completed - Clinical trials for Nutritional and Metabolic Diseases

Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients

Start date: May 2016
Phase: Early Phase 1
Study type: Interventional

The overall objective of the study is to examine the changes within the gut microbiome after the supplementation of inulin and its effect on markers of mineral metabolism and bone turnover.

NCT ID: NCT02716064 Completed - Hypertension Clinical Trials

TAPESTRY for People With Cardiovascular and Metabolic Disease: A Pilot Study

TAPESTRY-CM
Start date: December 2014
Phase: N/A
Study type: Interventional

TAPESTRY-CM pilot study is a 12-week pilot test of the TAPESTRY-CM using a web application (APP) to help patient manage their diabetes and hypertension and other chronic conditions by assisting them in setting goals and connecting them to their healthcare team.

NCT ID: NCT02715063 Completed - Overweight Clinical Trials

Cardiometabolic HIIT-RT Study

Start date: January 2016
Phase: N/A
Study type: Interventional

Several studies have shown relationship between exercise intensity and improvement cardiometabolic health such as body composition, endothelial function, blood pressure and blood lipids. It has been suggested that high intensity interval training and also strength or resistance training generate positive effects on metabolic risk factors, nevertheless the comparison between both types of training and their combination has not yet provided conclusive evidence. Also, it has been shown that dietary restriction has similar or more positive effects that exercise alone and the effect is greater when it is combined with exercise. For these reasons, it is necessary to clarify which type of training, in combination with a dietary restriction, is more effective to improve cardiometabolic health

NCT ID: NCT02698878 Completed - Clinical trials for Glucose Metabolism Disorders

Unloading Induced Effects on Local Glucose Uptake Into m. Soleus

NutriHEP
Start date: April 2014
Phase: N/A
Study type: Interventional

The present study aimed to investigate whether a daily intake of lupin protein and a neuromuscular electrical stimulation training twice a day can improve local glucose uptake into m. soleus during a 60 day unloading phase with a special unloading device, the HEPHAISTOS orthosis (HEP).

NCT ID: NCT02697305 Completed - Clinical trials for Glucose Metabolism Disorders

Incretin Effects of Branched Chain Amino Acids

Start date: September 2014
Phase: N/A
Study type: Interventional

Branched chain amino acids (BCAA) are known to exert insulinogenic effect. Whether this effect is mediated by incretins (GLP-1, GIP) is not known. The aim of the study was to show incretin effect of BCAA, i.e. whether the oral administration of BCAA elicits higher insulin and incretin response when compared with IV route of the same dose of BCAA. Eighteen healthy, male subjects participated in three tests: IV application of BCAA solution (30.7±1.1 g of BCAA, IV BCAA) second was oral ingestion of BCAA capsules in the same dose (ORAL BCAA) and third experiment was oral placebo (PLACEBO). Glucose, insulin, GLP-1, GIP, valine, leucine and isoleucine levels were measured at time interval for up to 4 h.

NCT ID: NCT02692911 Completed - Gallbladder Cancer Clinical Trials

Chile Biliary Longitudinal Study

Start date: January 11, 2017
Phase:
Study type: Observational

Background: The gallbladder is a small organ below the liver. Gallbladder cancer is a leading cause of cancer death among women in Chile. Chile also has among the highest rates of gallbladder cancer and death in the world. Researchers in a high-risk region of Chile want to find out more about this type of cancer. They especially want to know how inflammation affects the way it develops. Objective: To better understand the causes of gallbladder diseases and factors that may be associated with them. Eligibility: Women ages 50 74 with gallbladder cancer who are covered by the Chilean national health system. Other people over age 21 with gallbladder disease. Healthy adults over age 21. Design: Participants may be screened with an ultrasound. They may be asked questions about their health. Participants will have an ultrasound of the abdomen. This can be done at the study clinic or in the hospital or at home. The ultrasound uses sound waves to take pictures of the gallbladder. Participants will have a physical exam. Participants will have their mouths looked at for tooth loss, dentures, and gum redness. Participants will give a blood sample or saliva sample. Participants will be asked for access to their medical history. They may be asked to allow researchers to keep any samples taken during gallbladder surgery. Participants will answer questions about their medical history. This will include illnesses, surgeries, medicine use, and family history. It will also include diet and lifestyle habits, such as places where they have lived and worked. Some participants will have 3 follow-up visits over 6 years. ...

NCT ID: NCT02692495 Completed - Clinical trials for Nutritional and Metabolic Diseases

Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis

Start date: April 2009
Phase: N/A
Study type: Observational

This study is designed as a retrospective cohort study to evaluate the potential of diagnostic procedures in defining populations of patients self-reporting unexpected and uncontrollable episodes of body odor and/or halitosis. The cohort - generally healthy individuals who had underwent multiple diagnostic tests recommended by their physicians and had not been diagnosed with any known medical condition - expressed their interest in trying gastrointestinal and nutritional diagnostic tests offered by Biolab Medical Unit. Our retrospective analysis will determine if these tests were useful as potential screening tools for metabolic body odor and halitosis.

NCT ID: NCT02689765 Completed - Type 2 Diabetes Clinical Trials

Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetes

Start date: February 2016
Phase: Phase 4
Study type: Interventional

Metabolic problems represent one of the major health concerns which are attractive for being addressed by nutritional interventions, as these are directly connected to dietary habits.Anthocyans possess cardiovascular disease prevention, obesity control, and diabetes alleviation properties, but association between anthocyans and prediabetes need to be more firmly understood and established from robust clinical data. However, there is little human research that has reported on the efficacy of increased anthocyans bioactive consumption on insulin sensitivity in pre-diabetes.